// App-Quantinova.ai

2267 : Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment First Results of the Prospective Noac Registry (NCT01588119).

Researchers

Presenter

  • Christina Koehler

Principal Investigators

  • Sebastian Werth

  • Vera Gelbricht

  • Ulrike Haensel

  • Luise Tittl

  • Ines Beyer-Westendorf

  • Thomas Schreier

  • Maria Eulitz

  • Jan Beyer-Westendorf

Medical Centers

  • Vascular Medicine, Dresden University Hospital, Dresden, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved